What does ACCORD mean in MEDICAL
ACCORD stands for Action to Control Cardiovascular Risk in Diabetes. This acronym is used to describe a large-scale, randomized clinical trial of adults with type 2 diabetes that was conducted by the National Heart, Lung, and Blood Institute (NHLBI). The purpose of this study was to evaluate whether intensive control of blood sugar levels would reduce the risk of cardiovascular events such as heart attack and stroke in people with diabetes. The ACCORD trial began in 2001 and lasted until 2009, making it one of the largest and longest-running studies on diabetes ever conducted.
ACCORD meaning in Medical in Medical
ACCORD mostly used in an acronym Medical in Category Medical that means Action to Control Cardiovascular Risk in Diabetes
Shorthand: ACCORD,
Full Form: Action to Control Cardiovascular Risk in Diabetes
For more information of "Action to Control Cardiovascular Risk in Diabetes", see the section below.
Findings from ACCORD
The primary goal of the ACCORD trial was to determine whether intensive therapy to lower blood glucose levels (A1c) below 6% would reduce death from any cause compared to standard level therapy (A1c around 7-7.9%). While results showed that intensive treatment did not reduce mortality significantly compared to standard treatment among all participants in the trial, there were some subgroups that did benefit from intensive care: those aged 55-64 years old who had a history of cardiovascular disease were more likely to have improved outcomes with intensive care than those on standard care; however, when all patients aged 65+ years were included in this analysis there was no significant difference between groups. In addition, participants at high risk for developing major cardiovascular events may benefit from intense therapy because it could help delay their onset of these events by up to 4 years. Additionally, patients taking certain medications saw noticeable improvements in their safety profile when involved in intense treatment programs.
Essential Questions and Answers on Action to Control Cardiovascular Risk in Diabetes in "MEDICAL»MEDICAL"
What is Action to Control Cardiovascular Risk in Diabetes (ACCORD)?
ACCORD is a large clinical trial designed to compare intensive glycemic control with standard therapy and assess the effect on major cardiovascular events in individuals with Type 2 diabetes. The study also evaluates the effects of additional therapies such as lipid lowering drugs, blood pressure reduction drugs, and aspirin on major cardiovascular events.
Who can join ACCORD?
Participants must be at least 40 years old, have an established diagnosis of Type 2 Diabetes, and have evidence of existing cardiovascular disease or multiple risk factors for developing it.
How long do I need to participate in ACCORD?
The study includes between 8-10 visits over a period of five years. Annual follow up visits will occur after participation has ended.
Is there compensation for participating in ACCORD?
Yes, participants may be provided reasonable compensation for travel and time associated with participation.
Does ACCORD provide medications or treatments?
Yes. Certain participants may receive study medications or therapies free of charge during their involvement in the study. Some expenses related to care may also be covered if needed.
Are there any risks associated with being part of ACCORD?
As with any medical procedure or intervention, including study membership with ACCORD, there are certain risks associated with participation. The research team will discuss these potential risks prior to enrollment to ensure a participant’s full understanding.
What type of data will researchers collect while I am participating in the study?
Data collected during the course of the study can include physical measurements such as blood pressure readings and weight measurement; laboratory samples such as blood and urine specimens; demographic information such as age, gender, race/ethnicity; past medical history; and self-reported questionnaires related to health behaviors.
How will my results be used after I am enrolled in the study?
Results from all individuals enrolled in the trial are combined into one data set which is then analyzed by researchers studying various aspects of Type 2 diabetes. Results from this analysis may lead to new clinical guidelines for improved treatment options that could potentially benefit people living with diabetes worldwide.
Final Words:
The ACCORD study provides evidence that careful management of blood sugar levels through lifestyle modifications such as diet and exercise interventions along with medication may help reduce complications associated with type 2 diabetes and slow its progression. Intense glycemic control can also provide benefits for those individuals at greater risk for developing major cardiovascular events due to their age or prior medical history. Overall, this research highlights the importance of vigilance when it comes to managing a condition like type 2 diabetes in order to maximize health outcomes.